Convergente is the space to design and build better futures at the intersection of biology and technology.
We are a strategic joint venture between Noxgen, Allbiotech, and Vexxel, created to deploy scientific infrastructure, articulate knowledge, and consolidate Mexico City as the epicenter of biotechnological and deep tech investment in Latin America.
Why?
Biology is advancing at an exponential rate and has become the foundation of the next industrial revolution. Translating this scientific acceleration into economic sovereignty requires robust institutional and material scaffolding.
Convergente eliminates the region's structural barriers by providing the complete innovation cycle: from anticipatory regulatory intelligence to advanced laboratory infrastructure and catalytic capital.
Shared Lab & De-risking
We bridge the gap between the Seed round and Series A. We operate a residency program, a shared collaboratory, and a catalytic fund for deep tech startups to mitigate their technical risk and scale.
Ecosystem Articulation
We connect the actors leading the change. We facilitate a high-trust, low-friction social fabric where scientific talent, venture capital, and industry converge to experiment and collaborate.
.jpg)
